Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Raloxifene followed by combination therapy|DRUG: Exemestane followed by combination therapy
Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: Pharmacia